ANPI Angiotech Pharmaceuticals - Common Shares (MM)

VANCOUVER, Dec. 6 /PRNewswire-FirstCall/ -- Angiotech Pharmaceuticals, Inc. (NASDAQ:ANPINASDAQ:TSX:NASDAQ:ANP), a global specialty pharmaceutical and medical device company, is scheduled to participate in the RBC 2007 Healthcare Conference, which is being held December 12-13 in New York, NY. Tom Bailey, Angiotech's Chief Financial Officer, is scheduled to participate in a panel discussion on Thursday, December 13, at the Westin New York Times Square, beginning at approximately 9:00am ET. A live audio-only webcast will be available to all interested parties on the company's website, http://www.angiotech.com/ under the Investors section. About Angiotech Angiotech Pharmaceuticals, Inc. is a global specialty pharmaceutical and medical device company with over 1,500 dedicated employees. Angiotech discovers, develops and markets innovative treatment solutions for diseases or complications associated with medical device implants, surgical interventions and acute injury. To find out more about Angiotech (NASDAQ:ANPINASDAQ:TSX:NASDAQ:ANP), please visit our website at http://www.angiotech.com/. CONTACT: Deirdre Neary, Manager, Investor Relations, Angiotech Pharmaceuticals, Inc., (604) 222-7056, DATASOURCE: Angiotech Pharmaceuticals, Inc. CONTACT: Deirdre Neary, Manager, Investor Relations, Angiotech Pharmaceuticals, Inc., (604) 222-7056,

Copyright